Sino Biopharmaceutical Ltd
HKEX:1177

Watchlist Manager
Sino Biopharmaceutical Ltd Logo
Sino Biopharmaceutical Ltd
HKEX:1177
Watchlist
Price: 3.33 HKD 1.22%
Market Cap: 61.1B HKD
Have any thoughts about
Sino Biopharmaceutical Ltd?
Write Note

Sino Biopharmaceutical Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sino Biopharmaceutical Ltd
Interest Income Expense Peer Comparison

Comparables:
G
512
U
3933
C
570
C
3320
H
13

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Sino Biopharmaceutical Ltd
HKEX:1177
Interest Income Expense
-ÂĄ578.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
Interest Income Expense
HK$154.2m
CAGR 3-Years
-33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
U
United Laboratories International Holdings Ltd
HKEX:3933
Interest Income Expense
ÂĄ59m
CAGR 3-Years
N/A
CAGR 5-Years
-19%
CAGR 10-Years
-23%
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Interest Income Expense
-ÂĄ179.7m
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
-16%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Interest Income Expense
-HK$2B
CAGR 3-Years
1%
CAGR 5-Years
9%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Interest Income Expense
$46m
CAGR 3-Years
-21%
CAGR 5-Years
14%
CAGR 10-Years
15%

See Also

What is Sino Biopharmaceutical Ltd's Interest Income Expense?
Interest Income Expense
-578.8m CNY

Based on the financial report for Jun 30, 2024, Sino Biopharmaceutical Ltd's Interest Income Expense amounts to -578.8m CNY.

What is Sino Biopharmaceutical Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
57%

Over the last year, the Interest Income Expense growth was 57%.

Back to Top